Novel roles of intrine angiotensin II and signalling mechanisms in kidney cells

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 8, Issue 1, 2007, Pages 23-33

  Zhuo, Jia L ^a   Li, Xiao C ^b  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; AT1 receptor signalling; Endosomes; Kidney; Proximal tubule cells; Receptor endocytosis

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ARSENOSOBENZENE; CANDESARTAN; CELL NUCLEUS RECEPTOR; COLCHICINE; CYTOPLASMIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; SODIUM; THAPSIGARGIN;

CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARDIOVASCULAR DISEASE; CELL LEVEL; DRUG MECHANISM; ENDOCYTOSIS; ENDOSOME; ENZYME INHIBITION; FLUID RETENTION; HUMAN; HYPERTENSION; INTERNALIZATION; INTRACELLULAR TRANSPORT; KIDNEY CELL; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; MEDICAL RESEARCH; NONHUMAN; ORGAN INJURY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM RETENTION; TISSUE LEVEL; CYTOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANGIOTENSIN II; HUMANS; KIDNEY TUBULES, PROXIMAL; PROTEIN TRANSPORT; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 34249102220     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2007.003     Document Type: Review

References (134)

1. Tigerstedt R, Bergman PG. Kidney and circulation. Scand Arch Physiol 1898;8:223-71.
2. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
3. Johnston CI. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens Suppl 1992;10:513-S26.
4. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37:1047-52.
5. Paul M, Poyan MA, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803.
6. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology 2003; 144:2179-83.
7. Jan Danser AH, Saris JJ. Prorenin uptake in the heart: a prerequisite for local angiotensin generation? J Mol Cell Cardiol 2002; 34:1463-72.
8. Nguyen G. Renin/prorenin receptors. Kidney Int 2006; 69:1503-06.
9. Campbell DJ, Valentijn AJ. Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens 1994;12: 879-90.
10. Ihara M, Urata H, Kinoshita A et al. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999;33:1399-405.
11. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006; 47:515-21.
12. Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: functional implications. Front Neuroendocrinol 1995; 16:23-52.
13. Albiston AL, McDowall SG, Matsacos D et al. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001;276:48623-26.
14. Re RN. On the biological actions of intracellular angiotensin. Hypertension 2000;35:1189-90.
15. Peters J, Farrenkopf R, Clausmeyer S et al. Functional significance of prorenin internalization in the rat heart. Circ Res 2002;90:1135-41.
16. Cook JL, Zhang Z, Re RN. In vitro evidence for an intracellular site of angiotensin action. Circ Res 2001;89:1138-46.
17. De Mello WC, Danser AH. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension 2000;35:1183-8.
18. Filipeanu CM, Henning RH, Nelemans SA, de Zeeuw D. Intracellular angiotensin II: from myth to reality? JRAAS 2001;2:219-26.
19. Lavoie JL, Liu X, Bianco RA, Beltz TG, Johnson AK, Sigmund CD. Evidence supporting a functional role for intracellular renin in the brain. Hypertension 2006;47:461-6.
20. Robertson A, Khairallah P. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science 1971;172:1138-9.
21. Re RN. Intracellular renin and the nature of intracrine enzymes. Hypertension 2003;42:117-22.
22. Re RN, Vizard DL, Brown J, LeGros L, Bryan SE. Angiotensin II receptors in chromatin. J Hypertens Suppl 1984;2:S271-S273.
23. Cook JL, Zhang Z, Re RN. Intracellular angiostensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. J Mol Cell Cardiol 2002;34:1525-37.
24. 1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation. J Mol Cell Cardiol 2006;40:696-707.
25. De Mello WC. Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes. Hypertension 1998;32:976-82.
26. De Mello WC. Renin-angiotensin system and cell communication in the failing heart. Hypertension 1996;27:1267-72.
27. De Mello WC. Renin increments the inward calcium current in the failing heart. J Hypertens 2006;24:1181-6.
28. Haller H, Lindschau C, Erdmann B, Quass P, Luft FC. Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 1996;79:765-72.
29. Haller H, Lindschau C, Quass P, Luft FC. Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 1999;10(suppl 11):S75-S83.
30. Danser AH, Deinum J. Renin, proreinin and the putative (pro)renin receptor. Hypertension 2005;46:1069-76.
31. Saris JJ, Hoen PA, Garrelds IM et al. Prorenin induces intracellular signalling in cardiomyocytes independently of angiotensin II. Hypertension 2006;48:564-71.
32. von Thun AM, Vari RC, El Dahr SS, Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol 1994;266:F120-F128.
33. Zou LX, Hymel A, Imig JD, Navar LG. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 1996;27:658-62.
34. van Kats JP, Schalekamp MA, Verdouw PD, Duncker DJ, Danser AH. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001;60:2311-17.
35. Johnson RJ, Alpers CE, Yoshimura A et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19:464-74.
36. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 2002;39:116-21.
37. Douglas JG, Hopfer U. Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu Rev Physiol 1994; 56:649-69.
38. Navar LG, Carmines PK, Huang WC, Mitchell KD. The tubular effects of angiotensin II. Kidney Int Suppl 1987;20:581-588.
39. Harris PJ, Navar LG. Tubular transport responses to angiotensin II. Am J Physiol Renal Physiol 1985;248:F621-F630.
40. Zhuo JL, Allen AM, Alcorn D, MacGregor D, Aldred GP, Mendelsohn FA. The distribution of angiotensin II receptors. Laragh, J. H. and Brenner, B. M. (eds.) Hypertension: Pathology, Diagnosis & Management. 1[2nd Edition], New York: Raven Press, 1995:1739-62.
41. Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 2006;17:2985-91.
42. Thomas WG, Thekkumkara TJ, Baker KM. Molecular mechanisms of angiotensin II (AT1A) receptor endocytosis. Clin Exp Pharmacol Physiol Suppl 1996;3:S74-S80.
43. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signalling. Pharmacol Rev 2001;53:1-24.
44. Gonzalez-Gaitan M. Signal dispersal and transduction through the endocytic pathway. Nat Rev Mol Cell Biol 2003; 4:213-24.
45. 1 receptors in proximal tubule cells. Am J Physiol Renal Physiol 2006;290:F1382-F1390.
46. 1a receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases. Am J Physiol Renal Physio 2006;291:F375-F383.
47. Ruiz-Ortega M, Ruperez M, Lorenzo O et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002;82:12-22.
48. Muller DN, Dechend R, Mervaala EM et al. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000;35:193-201.
49. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.
50. Mendelsohn FA. Angiotensin II: evidence for its role as an intrarenal hormone. Kidney Int Suppl 1982;12:S78-S81.
51. Tang SS, Jung F, Diamant D et al. Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am J Physiol 1995;268:F435-F446.
52. Zhuo JL, Mendelsohn FA. Intrarenal Angiotensin II Receptors. Robertson JIS and Nicholls MG (eds) The Renin-Angiotensin System: Biochemistry, Pathophysiology and Therapeutics. London & New York, Gower Medical Publishing, 1993:25.1-25.14.
53. Navar LG, Imig JD, Zou L, Wang CT. Intrarenal production of angiotensin II. Semin Nephrol 1997;17:412-22.
54. Harrison-Bernard LM, Zhuo J, Kobori H, Ohishi M, Navar LG. Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 2002;282:F19-F25.
55. Ingelfinger JR, Jung F, Diamant D et al. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol 1999;276:F218-F227.
56. Tang SS, Jung F, Diamant D et al. Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am J Physiol 1995;268:F435-F446.
57. Douglas JG. Angiotensin receptor subtypes of the kidney cortex. Am J Physiol 1987;253:F1-F7.
58. Zhuo J, Alcom D, Harris PJ, Mendelsohn FA. Localization and properties of angiotensin II receptors in rat kidney. Kidney Int Suppl 1993;42:S40-S46.
59. Dulin NO, Ernsberger P, Suciu DJ, Douglas JG. Rabbit renal epithelial angiotensin II receptors. Am J Physiol 1994;267:F776-F782.
60. Zhuo J, Song K, Harris PJ, Mendelsohn FA. In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem 1992;15:231-9.
61. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72.
62. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991;351:233-6.
63. Mehta PK, Griendling KK. Angiotensin II cell signalling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97.
64. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990;15:451-8.
65. Zhuo J, Thomas D, Harris PJ, Skinner SL. The role of endogenous angiotensin II in the regulation of renal haemodynamics and proximal fluid reabsorption in the rat. J Physiol 1992;453:1-13.
66. Wolf G, Ziyadeh FN. Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 1997;17:448-54.
67. Luft FC. Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 2002;11:59-66.
68. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001; 10:321-9.
69. Wolf G, Ziyadeh FN, Zahner G, Stahl RA. Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogene. Kidney Int 1995;48:1818-27.
70. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-72.
71. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72.
72. Schelling JR, Singh H, Marzec R, Linas SL. Angiotensin II-dependent proximal tubule sodium transport is mediated by cAMP modulation of phospholipase C. Am J Physiol 1994;267:C1239-C1245.
73. Thekkumkara TJ, Cookson R, Linas SL. Angiotensin (AT1A) receptor-mediated increases in transcellular sodium transport in proximal tubule cells. Am J Physiol 1998;274:F897-F905.
74. Carey RM, Wang ZQ, Siragy HM. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 2000;35:155-63.
75. Hakam AC, Hussain T. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+- ATPase activity via a NO/cGMP-dependent pathway. Am J Physiol Renal Physiol 2006;290:F1430-F1436.
76. Siragy HM, Carey RM. Angiotensin type 2 receptors: potential importance in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2001;10:99-103.
77. De Mello WC. Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J Cardiovasc Pharmacol 1994;23:640-6.
78. Re R, Parab M. Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci 1984;34:647-51.
79. Navar LG, Lewis L, Hymel A, Braam B, Mitchell KD. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994;5:1153-8.
80. Navar LG, Harrison-Bernard LM, Wang CT, Cervenka L, Mitchell KD. Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 1999;10(suppl 11): S189-S195.
81. Seikaly MG, Arant BS Jr., Seney FD Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352-7.
82. Braam B, Mitchell KD, Fox J, Navar LG. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993;264:F891-F898.
83. Mitchell KD, Jacinto SM, Mullins JJ. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol 1997; 273:F246-F253.
84. Siragy HM, Howell NL, Ragsdale NV, Carey RM. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 1995;25:1021-4.
85. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002;39:129-34.
86. van Kats JP, van Meegen JR, Verdouw PD, Duncker DJ, Schalekamp MA, Danser AH. Subcellular localization of angiotensin II in kidney and adrenal. J Hypertens 2001;19:583-9.
87. Zou LX, Imig JD, Hymel A, Navar LG. Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor. Am J Hypertens 1998;11:570-8.
88. van Kats JP, de Lannoy LM, Jan Danser AH, van Meegen JR, Verdouw PD, Schalekamp MA. Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension 1997;30:42-9.
89. Zou LX, Imig JD, von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 1996;28:669-77.
90. Ingert C, Grima M, Coquard C, Barthelmebs M, Imbs JL. Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats. Am J Physiol Renal Physiol 2002; 283:F1003-F1010.
91. Hein L, Meinel L, Pratt RE, Dzau VJ, Kobilka BK. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 1997;11:1266-77.
92. Imig JD, Navar GL, Zou LX et al. Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors. Am J Physiol 1999;277:F303-F311.
93. Linas SL. Role of receptor mediated endocytosis in proximal tubule epithelial function. Kidney Int Suppl 1997;61:S18-S21.
94. Thekkumkara T, Linas SL. Role of internalization in AT(1A) receptor function in proximal tubule epithelium. Am J Physiol Renal Physiol 2002;282:F623-F629.
95. Romero MF, Hopfer U, Madhun ZT, Zhuo W, Douglas JG. Angiotensin actions in the rabbit proximal tubule. Ren Physiol Biochem 2003; 14:199-207.
96. Romero MF, Douglas JG, Eckert RL, Hopfer U, Jacobberger JW. Development and characterization of rabbit proximal tubular epithelial cell lines. Kidney Int 1992;42:1130-44.
97. Chen R, Mukhin YV, Garnovskaya MN et al. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 2000; 279:F440-F448.
98. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, Chappell MC. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol 2006;290:F1497-F1506.
99. 1A receptor associated with nuclear activation. Am J Physiol Cell Physiol 2007;292:1398-408.
100. Licea H, Walters MR, Navar LG. Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hung 2002; 89:427-38.
101. Timmermans PB, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-51.
102. Zhuo JL, Moeller I, Jenkins T et al. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors. J Hypertens 1997;16:2027-37.
103. Ullian ME, Linas SL. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest 1989;84:840-6.
104. Anderson KM, Peach MJ. Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: morphological analysis of angiotensin II processing in isolated vascular strips. J Vasc Res 1994;31:10-17.
105. Schelling JR, Linas SL. Angiotensin II-dependent proximal tubule sodium transport requires receptor-mediated endocytosis. Am J Physiol 1994;266:0669-C675.
106. Schelling JR, Hanson AS, Marzec R, Linas SL. Cytoskeleton-dependent endocytosis is required for apical type 1 angiotensin II receptor-mediated phospholipase C activation in cultured rat proximal tubule cells. J Clin Invest 1992;90:2472-80.
107. Anborgh PH, Seachrist JL, Dale LB, Ferguson SS. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors. Mol Endocrinol 2000; 14:2040-53.
108. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MA, Jr., Alexander RW. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem 1987; 262:14555-62.
109. Sen I, Bull HG, Soffer RL. Isolation of an angiotensin II-binding protein from liver. Proc Natl Acad Sci USA 1984;81:1679-83.
110. Tang SS, Rogg H, Schumacher R, Dzau VJ. Characterization of nucler angiotensin II binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 1992;131:374-80.
111. Zhuo JL. Intracrine renin and angiotensin II: a novel role in cardiovascular and renal cellular regulation. J Hypertens 2006; 24:1017-20.
112. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 2002; 61:1986-95.
113. Suzuki Y, Ruiz-Ortega M, Egido J. Angiotensin II: a double-edged sword in inflammation. J Nephrol 2000;13 (suppl 3):S101-S110.
114. Kwon TH, Nielsen J, Kim YH, Knepper MA, Frokiaer J, Nielsen S. Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol 2003;285:F152-F165.
115. Brooks HL, Allred AJ, Beutler KT, Coffman TM, Knepper MA. Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension 2002;39:470-3.
116. Beutler KT, Masilamani S, Turban S et al. Long-Term Regulation of ENaC Expression in Kidney by Angiotensin II. Hypertension 2003; 41:1143-50.
117. Kurtz TW, Gardner DG. Transcription-modulating drugs: a new frontier in the treatment of essential hypertension. Hypertension 1998; 32:380-6.
118. du CD, Chalumeau C, Defontaine N et al. Angiotensin II stimulates NHE3 activity by exocytic insertion of the transporter: role of PI 3-kinase. Kidney Int 2003;64:939-49.
119. Moe OW. Acute regulation of proximal tubule apical membrane Na?H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol 1999;10:2412-25.
120. Turban S, Beutler KT, Morris RG, Masilamani S, Fenton RA, Knepper MA, Packer RK. Long-term regulation of proximal tubule acid-base transporter abundance by angiotensin II. Kidney Int 2006;70:660-8.
121. Zhuo JL. Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease? J Hypertens 2004;22:451-4.
122. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1992;188:257-64.
123. Marrero MB, Schieffer B, Paxton WG et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995;375:247-50.
124. Schmitz U, Ishida T, Ishida M et al. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res 1998;82:1272-8.
125. Molkentin JD, Lu JR, Antos CL et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93:215-28.
126. Lucchesi PA, Bell JM, Willis LS, Byron KL, Corson MA, Berk BC. Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype. Circ Res 1996; 78:962-70.
127. Mitsuka M, Nagae M, Berk BC. Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation. Circ Res 1993;73:269-75.
128. Jimenez E, Vinson GP, Montiel M. Angiotensin II (AII)-binding sites in nuclei from rat liver: partial characterization of the mechanisms of Ang II accumulation in nuclei. J Endocrinol 1994;143:449-53.
129. Muller DN, Heissmeyer V, Dechend R et al. Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. FASEB J 2001;15:1822-4.
130. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 2001;38:635-8.
131. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signalling module: temporal control and selective gene activation. Science 2002;298:1241-5.
132. Stancovski I, Baltimore D. NF-kappaB activation: the I kappaB kinase revealed? Cell 1997;91:299-302.
133. Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 2001;158:1743-56.
134. 1a receptor-mediated endocytosis of extracellular angiotensin II on activation of nuclear factor-KB in proximal tubule cells. Ann NY Acad Sci 2006;1091:336-45.